The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 10, Pages e884-e884
Publisher
Springer Nature
Online
2013-10-24
DOI
10.1038/cddis.2013.416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
- (2013) Kornelius Kerl et al. BMC CANCER
- Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells
- (2013) Thippeswamy Gulappa et al. CANCER LETTERS
- Histone deacetylases as targets for treatment of multiple diseases
- (2013) Jinhua Tang et al. CLINICAL SCIENCE
- Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis
- (2013) Katrien Van Beneden et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Multiple roles of class I HDACs in proliferation, differentiation, and development
- (2012) Nina Reichert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Unknown
- (2012) Eun Shin et al. MOLECULAR MEDICINE
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- TGF-β Signaling via TAK1 Pathway: Role in Kidney Fibrosis
- (2012) Mary E. Choi et al. SEMINARS IN NEPHROLOGY
- PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies
- (2012) Lise Willems et al. Current Oncology Reports
- Interplay between HDAC3 and WDR5 Is Essential for Hypoxia-Induced Epithelial-Mesenchymal Transition
- (2011) Min-Zu Wu et al. MOLECULAR CELL
- Pathological roles of MAPK signaling pathways in human diseases
- (2010) Eun Kyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Balancing the decision of cell proliferation and cell fate
- (2010) Timothy C. Hallstrom et al. CELL CYCLE
- The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
- (2010) Zhiwei Wang et al. CURRENT DRUG TARGETS
- Histone deacetylase 1 is required for transforming growth factor-β1-induced epithelial–mesenchymal transition
- (2010) Weiwei Lei et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting the jagged/notch pathway: a new treatment for fibrosis?
- (2010) Andrew Leask Journal of Cell Communication and Signaling
- Posterior Capsular Opacification
- (2009) Niranjan Awasthi ARCHIVES OF OPHTHALMOLOGY
- Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors
- (2009) Annunziata Gloghini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation
- (2008) Zahra Nathu et al. EXPERIMENTAL EYE RESEARCH
- Histone Deacetylation
- (2008) Anas Al-Janadi et al. Drugs in research & development
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More